Compositions And Methods For The Alteration Of Xlhed Phenotypes


Ontology type: sgo:Patent     


Patent Info

DATE

N/A

AUTHORS

SCHNEIDER, PASCAL , KOWALCZYK, Christine

ABSTRACT

The invention relates to methods for the temporal administration of EDA agonists, in particular EDI200, which correlate to optimal therapeutic response windows required for the formation of any EDA-dependent structures such as ectodermal appendages. Use of the methods described allow for the design of targeted therapeutic dosing and administration regimens in order to correct or alter abnormal phenotypes associated with genetic disorders, in particular, XLHED. More... »

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2620", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "SCHNEIDER, PASCAL", 
        "type": "Person"
      }, 
      {
        "name": "KOWALCZYK, Christine", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nm861", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021994509", 
          "https://doi.org/10.1038/nm861"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ajmg.a.32916", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045568620"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/521988", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058793391"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "description": "

The invention relates to methods for the temporal administration of EDA agonists, in particular EDI200, which correlate to optimal therapeutic response windows required for the formation of any EDA-dependent structures such as ectodermal appendages. Use of the methods described allow for the design of targeted therapeutic dosing and administration regimens in order to correct or alter abnormal phenotypes associated with genetic disorders, in particular, XLHED.

", "id": "sg:patent.EP-2697258-A1", "keywords": [ "composition", "phenotype", "invention", "method", "agonist", "therapeutic response", "EDA", "appendage", "targeted therapeutic", "regimen", "abnormal phenotype", "genetic disorder" ], "name": "COMPOSITIONS AND METHODS FOR THE ALTERATION OF XLHED PHENOTYPES", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.467356.5", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/EP-2697258-A1" ], "sdDataset": "patents", "sdDatePublished": "2019-03-07T15:36", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com.uberresearch.data.dev.patents-pipeline/full_run_10/sn-export/5eb3e5a348d7f117b22cc85fb0b02730/0000100128-0000348334/json_export_c290c18d.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.EP-2697258-A1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.EP-2697258-A1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.EP-2697258-A1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.EP-2697258-A1'


 

This table displays all metadata directly associated to this object as RDF triples.

47 TRIPLES      14 PREDICATES      28 URIs      19 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.EP-2697258-A1 schema:about anzsrc-for:2620
2 schema:author N5bf630e9ea674779acab2b870844ad98
3 schema:citation sg:pub.10.1038/nm861
4 https://doi.org/10.1002/ajmg.a.32916
5 https://doi.org/10.1086/521988
6 schema:description <p>The invention relates to methods for the temporal administration of EDA agonists, in particular EDI200, which correlate to optimal therapeutic response windows required for the formation of any EDA-dependent structures such as ectodermal appendages. Use of the methods described allow for the design of targeted therapeutic dosing and administration regimens in order to correct or alter abnormal phenotypes associated with genetic disorders, in particular, XLHED.</p>
7 schema:keywords EDA
8 abnormal phenotype
9 agonist
10 appendage
11 composition
12 genetic disorder
13 invention
14 method
15 phenotype
16 regimen
17 targeted therapeutic
18 therapeutic response
19 schema:name COMPOSITIONS AND METHODS FOR THE ALTERATION OF XLHED PHENOTYPES
20 schema:recipient https://www.grid.ac/institutes/grid.467356.5
21 schema:sameAs https://app.dimensions.ai/details/patent/EP-2697258-A1
22 schema:sdDatePublished 2019-03-07T15:36
23 schema:sdLicense https://scigraph.springernature.com/explorer/license/
24 schema:sdPublisher N90548462646443698fa039554ac9e279
25 sgo:license sg:explorer/license/
26 sgo:sdDataset patents
27 rdf:type sgo:Patent
28 N2f2ad26fd85249cea1caa07c7ac6037b schema:name SCHNEIDER, PASCAL
29 rdf:type schema:Person
30 N5bf630e9ea674779acab2b870844ad98 rdf:first N2f2ad26fd85249cea1caa07c7ac6037b
31 rdf:rest Nc3e49e5592be41d3b8d85161499a3ad1
32 N626d11de25f943079948a64a04daa536 schema:name KOWALCZYK, Christine
33 rdf:type schema:Person
34 N90548462646443698fa039554ac9e279 schema:name Springer Nature - SN SciGraph project
35 rdf:type schema:Organization
36 Nc3e49e5592be41d3b8d85161499a3ad1 rdf:first N626d11de25f943079948a64a04daa536
37 rdf:rest rdf:nil
38 anzsrc-for:2620 schema:inDefinedTermSet anzsrc-for:
39 rdf:type schema:DefinedTerm
40 sg:pub.10.1038/nm861 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021994509
41 https://doi.org/10.1038/nm861
42 rdf:type schema:CreativeWork
43 https://doi.org/10.1002/ajmg.a.32916 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045568620
44 rdf:type schema:CreativeWork
45 https://doi.org/10.1086/521988 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058793391
46 rdf:type schema:CreativeWork
47 https://www.grid.ac/institutes/grid.467356.5 schema:Organization
 




Preview window. Press ESC to close (or click here)


...